David Hoey, CEO, has more than 25 years of executive-level experience in business development, licensing, strategic planning, and financing for technology companies. His experience spans preclinical and clinical development of therapeutics and vaccines, and molecular diagnostic assays and platforms. Mr. Hoey has completed over $425 million in corporate partnering transactions and equity financings in the United States, Europe, and Japan and has secured extensive contracts for government sponsored research. Mr. Hoey is a board member of publicly listed Universal Biosensors Pty. Ltd.
David Hoey
Related people
All People
David Asch
Behavioral Economist
David R. Williams
Public Health Sociologist
Jason Shepherd
Neurobiologist
David Pogue
Technology Columnist, New York Times
David Casarett
Doctorly Detective
Emily F. Rothman
Pornography Literacy Scientist
David Glickman
COO & Co-founder
Dave Gallo
Director of Special Projects, Woods Hole Oceanographic Inst
David Lucchino
Co-Founder & CEO
David Agus
Professor of Medicine and Engineering, University of Southern California | Author, "The End of Illness"
David Odde & Black Label Movement
Professor and Director of Undergraduate Studies, Department of Biomedical Engineering, University of Minnesota | Dance Theatre
David Brooks
Founder + CEO